Publication | Closed Access
Efficacy of Caffeine in <scp>ADCY5</scp>‐Related Dyskinesia: A Retrospective Study
46
Citations
10
References
2022
Year
Our findings suggest that caffeine should be considered as a first-line therapeutic option in ADCY5-related dyskinesia. © 2022 International Parkinson and Movement Disorder Society.
| Year | Citations | |
|---|---|---|
Page 1
Page 1